» Articles » PMID: 15705880

CpG Island Methylator Phenotype is a Strong Determinant of Poor Prognosis in Neuroblastomas

Overview
Journal Cancer Res
Specialty Oncology
Date 2005 Feb 12
PMID 15705880
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroblastoma, one of the most common pediatric solid tumors, is characterized by two extreme disease courses, spontaneous regression and life-threatening progression. Here, we conducted a genome-wide search for differences in DNA methylation that distinguish between neuroblastomas of the two types. Three CpG islands (CGI) and two groups of CGIs were found to be methylated specifically in neuroblastomas with a poor prognosis. By quantitative analysis of 140 independent cases, methylation of all the five CGI (groups) was shown to be closely associated with each other, conforming to the CpG island methylator phenotype (CIMP) concept. The presence of CIMP was sensitively detected by methylation of the PCDHB CGIs and associated with significantly poor survival (hazard ratio, 22.1; 95% confidence interval, 5.3-93.4; P < 0.0001). Almost all cases with N-myc amplification (37 of 38 cases) exhibited CIMP. Even in 102 cases without N-myc amplification, the presence of CIMP (30 cases) strongly predicted poor survival (hazard ratio, 12.4; 95% confidence interval, 2.6-58.9; P = 0.002). Methylation of PCDHB CGIs, located in their gene bodies, did not suppress gene expression or induce histone modifications. However, CIMP was significantly associated with methylation of promoter CGIs of the RASSF1A and BLU tumor suppressor genes. The results showed that neuroblastomas with CIMP have a poor prognosis and suggested induction of silencing of important genes as an underlying mechanism.

Citing Articles

Prediction of Composite Clinical Outcomes for Childhood Neuroblastoma Using Multi-Omics Data and Machine Learning.

Wang P, Zhang J Int J Mol Sci. 2025; 26(1.

PMID: 39795994 PMC: 11720239. DOI: 10.3390/ijms26010136.


Cisplatin resistance-related transcriptome and methylome integration identifies as a novel prognostic biomarker in small cell lung cancer.

Zhu Q, Fu M, Qi J, Xu Z, Wang Y, Wang Z iScience. 2024; 27(8):110413.

PMID: 39108724 PMC: 11301104. DOI: 10.1016/j.isci.2024.110413.


Targeting DNA Methylation Machinery in Pediatric Solid Tumors.

Cristalli C, Scotlandi K Cells. 2024; 13(14.

PMID: 39056791 PMC: 11275080. DOI: 10.3390/cells13141209.


Epigenetic Dysregulation in -Amplified Neuroblastoma.

Epp S, Chuah S, Halasz M Int J Mol Sci. 2023; 24(23).

PMID: 38069407 PMC: 10707345. DOI: 10.3390/ijms242317085.


The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN.

Ando K, Nakagawara A Cells. 2023; 12(4).

PMID: 36831211 PMC: 9954111. DOI: 10.3390/cells12040544.